Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial

Lancet Neurology
Richard A C HughesICE Study Group

Abstract

Short-term studies suggest that intravenous immunoglobulin might reduce disability caused by chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) but long-term effects have not been shown. We aimed to establish whether 10% caprylate-chromatography purified immune globulin intravenous (IGIV-C) has short-term and long-term benefit in patients with CIDP. 117 patients with CIDP who met specific neurophysiological inflammatory neuropathy cause and treatment (INCAT) criteria participated in a randomised, double-blind, placebo-controlled, response-conditional crossover trial. IGIV-C (Gamunex) or placebo was given every 3 weeks for up to 24 weeks in an initial treatment period, and patients who did not show an improvement in INCAT disability score of 1 point or more received the alternate treatment in a crossover period. The primary outcome was the percentage of patients who had maintained an improvement from baseline in adjusted INCAT disability score of 1 point or more through to week 24. Patients who showed an improvement and completed 24 weeks of treatment were eligible to be randomly re-assigned in a blinded 24-week extension phase. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, n...Continue Reading

References

Apr 1, 1976·Journal of the Neurological Sciences·J W Prineas, J G McLeod
Apr 21, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·M P LunnP K Thomas
Aug 17, 2001·Annals of Neurology·R HughesUNKNOWN Inflammatory Neuropathy Cause and Treatment (INCAT) Group
Mar 1, 2002·Muscle & Nerve·Ingemar S J MerkiesPieter A Van Doorn
Dec 18, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·I S J MerkiesUNKNOWN Inflammatory Neuropathy Cause and Treatment (INCAT) Group
Dec 25, 2002·Neurology·Norman Latov
Apr 1, 2005·The New England Journal of Medicine·Hubertus KöllerHans-Peter Hartung
Mar 8, 2006·Journal of the Peripheral Nervous System : JPNS·Richard A C HughesNorman A Gregson

❮ Previous
Next ❯

Citations

Aug 6, 2008·Der Nervenarzt·S Cursiefen, M Mäurer
Sep 20, 2008·Journal of Neurology·Richard Hughes
Sep 20, 2008·Journal of Neurology·Richard Hughes
Jun 19, 2013·Journal of Neurology·Pierre LozeronNathalie Kubis
Jun 25, 2010·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Patrizia DacciRaffaella Fazio
Apr 29, 2010·Journal of Clinical Immunology·Björn TackenbergJan D Lünemann
Apr 16, 2010·Journal of Clinical Immunology·Richard Hughes
Apr 15, 2009·Current Treatment Options in Neurology·Suraj Ashok Muley, Gareth J Parry
Sep 16, 2010·Current Treatment Options in Neurology·Eliza E Robertson, Peter D Donofrio
Jan 19, 2011·Current Treatment Options in Neurology·Glenn Lopate, Alan Pestronk
Sep 14, 2011·Current Treatment Options in Neurology·Hugh J McMillanPeter B Kang
Apr 9, 2013·Current Treatment Options in Neurology·Mazen M Dimachkie, Richard J Barohn
Jul 11, 2009·Clinical Reviews in Allergy & Immunology·Shaye KivityYehuda Shoenfeld
Jun 25, 2013·Trends in Pharmacological Sciences·Mathias ButtmannHans-Peter Hartung
Jun 23, 2009·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·J-M Pédespan, S Meyer-Witte
May 15, 2012·Lancet Neurology·Ivo N van Schaik
Apr 17, 2008·Nature Clinical Practice. Neurology·Eduardo Nobile-Orazio
Mar 6, 2009·Nature Clinical Practice. Neurology·John W Griffin, Richard A C Hughes
Aug 17, 2011·Nature Reviews. Neurology·Marinos C Dalakas, UNKNOWN Medscape
May 4, 2011·Nature Reviews. Neurology·Hans-Peter HartungHugh J Willison
May 11, 2011·Nature Reviews. Rheumatology·Jagadeesh BayrySrini V Kaveri
Nov 23, 2012·The New England Journal of Medicine·Erwin W Gelfand
Mar 6, 2009·Proceedings of the National Academy of Sciences of the United States of America·Björn TackenbergJan D Lünemann
Dec 23, 2011·Brain : a Journal of Neurology·Els Karla VanhoutteUNKNOWN PeriNomS Study Group
Aug 28, 2012·Journal of Clinical Neuromuscular Disease·Carolina BarnettVera Bril
May 29, 2008·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Y L LoP Ratnagopal
Sep 18, 2008·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·I ElovaaraUNKNOWN EFNS
Oct 30, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·D CocitoUNKNOWN Italian Network for CIDP Register
Oct 23, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Y A Rajabally
Jan 12, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A B BohnM E Hokland
Aug 16, 2012·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·E K VanhoutteI S J Merkies
Mar 20, 2012·The Journal of Clinical Investigation·Michael A MaurerJan D Lünemann
Jul 1, 2008·Therapeutic Advances in Neurological Disorders·Gordon Mallarkey
Sep 1, 2008·Therapeutic Advances in Neurological Disorders·Martin Stangel
Jun 23, 2011·Therapeutic Advances in Neurological Disorders·Min-Suk YoonRalf Gold
Nov 10, 2012·Therapeutic Advances in Neurological Disorders·Kenneth C Gorson
Sep 14, 2010·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Christian A VedelerJan Aasly
Jul 21, 2010·Neurology India·Kamakshi PatelSuraj Ashok Muley
Sep 28, 2013·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·A KerasnoudisM-S Yoon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.